Panacea Global Inc (OTCQB:PANG)

Data as of 3:54pm ET
 -0.075 / -33.33%
Today’s Change
Today|||52-Week Range
Real Estate Development

Company Description

Panacea Global, Inc. is a biotechnology company focused on the discovery, development and commercialization of diagnostic products for the management of cancer. The company provides blood, serum and tissue tests to diagnose and monitor cancer through a licensing agreement with Panacea Pharmaceuticals. Its current product line allows for accurate detection of the most common forms of cancer, which includes diagnostic tests for lung, breast, prostate and colon cancers. The company was founded in 1995 and is headquartered in Richmond Hill, Canada.

Contact Information

Panacea Global, Inc.
330 Highway 7 East
Richmond Hill Ontario L4B 3P8
P:(416) 450-6414
Investor Relations:



Individual stakeholders14.80%
Mutual fund holders--
Other institutional--

Top Executives

Mahmood MoshiriPresident, CEO, CFO & Director
Binnay SethiSecretary, Director & Vice President

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.